臨床婦人科産科77巻5号

2023年05月発行

今月の臨床 産科救急―意識障害と危機的出血の初期対応 産科危機的出血への対応

緊急輸血・血液製剤投与

著者： 松永茂剛¹

所属機関： ¹埼玉医科大学総合医療センター産婦人科

ページ範囲：P.488 - P.494

●大量輸血の予測因子として最も優れたパラメータはフィブリノゲン値である．

●フィブリノゲン測定については，POCTを用いて迅速に測定できるようになってきている．

●フィブリノゲン製剤の保険適用により速やかなフィブリノゲン補充が可能となってきており，patient blood managementに基づいた輸血療法が実施可能となりつつある．

参考文献

1）日本産婦人科医会妊産婦死亡症例検討評価委員会：母体安全への提言2020，vol. 11．2021年9月

2）Aitkenhead A, et al（eds）：Textbook of Anaesthesia, 4th eds. Churchill Livingstone, London, 2002

3）Bose P, et al : Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 113 : 919-924, 2006

4）日本産科婦人科学会，他：産科危機的出血への対応指針2022．2022

5）Nathan HL, et al : Shock index : an effective predictor of outcome in postpartum haemorrhage? BJOG 122 : 268-275, 2015

6）El Ayadi AM, et al : Vital sign prediction of adverse maternal outcomes in women with hypovolemic shock : the role of shock index. PLoS One 11 : e0148729, 2016

7）Era S, et al : Usefulness of shock indicators for determining the need for blood transfusion after massive obstetric hemorrhage. J Obstet Gynaecol Res 41 : 39-43, 2015

8）Cerneca F, et al : Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 73 : 31-36, 1997

9）Matsunaga S, et al : A retrospective analysis of transfusion management for obstetric hemorrhage in a Japanese obstetric center. ISRN Obstet Gynecol 2012 : 854064, 2012

10）Huissoud C, et al : Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 116 : 1097-1102, 2009

11）Nakamura E, et al : Comparative retrospective study on the validity of point-of-care testing device for massive obstetrical hemorrhage : dry hematology vs thromboelastography. Am J Obstet Gynecol MFM 5 : 100778, 2022

12）Murphy MF, et al : Guidelines for the clinical use of red cell transfusions. Bri J Haematol 113 : 24-31, 2001

13）厚生労働省食品局血液対策課：血液製剤の使用指針，改定版．2005年9月

14）Stinger HK, et al : The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 64 : S79-S85 ; discussion S85, 2008

15）Borgman MA, et al : The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 63 : 805-813, 2007

16）Matsunaga S, et al : The clinical efficacy of fibrinogen concentrate in massive obstetric haemorrhage with hypofibrinogenaemia. Sci Rep 7 : 46749, 2017

17）The L：WOMAN : reducing maternal deaths with tranexamic acid. Lancet 389 : 2081, 2017

18）Ker K, et al : Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev 5 : CD004896, 2015

19）CRASH-2 trial collaborators；et al : Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage（CRASH-2）: a randomised, placebo-controlled trial. Lancet 376 : 23-32, 2010